Analyst: Tesla’s Terafab push for chip output could slip to around 2030, despite Musk’s late-2028 goal

Elon Musk’s Terafab semiconductor project is attracting fresh scrutiny after a chip analyst suggested that even if the company can build the factory quickly, moving from construction to commercially meaningful chip output may take longer. The comments, reported by Benzinga through Yahoo Finance, put a later timeline on what Tesla can deliver at scale from Terafab, compared with Musk’s stated target.

According to the report, Musk has said he wants Terafab to be producing chips at scale by late 2028. The plan, as characterized in the discussion, centers on making the manufacturing process fast enough to support high-volume production rather than relying on slower external supply chains.

The analyst’s view diverged on timing for real-world scale. While he argued that Musk could build Terafab “faster than anyone,” the analyst also said that mass production of commercially significant volume may not begin until about 2030.

The report frames the difference as less about factory construction and more about the production ramp. In semiconductor manufacturing, a factory can be completed and equipment can be installed, but reaching repeatable yields and consistent output typically requires extended commissioning and process tuning. That gap between “build” and “scale” is what the analyst highlighted in linking Terafab’s output timeline to around 2030.

For Tesla, the stakes are straightforward. As a carmaker moves deeper into software-defined vehicles and advanced driver assistance features, it increases dependence on specialized chips and the ability to secure supply. Any delay in semiconductor production at a planned facility can matter for long-range planning, especially when the company’s vehicle production and product cadence are tightly managed.

More broadly, the Terafab discussion is part of a wider industry trend in which ambitious chip strategies increasingly depend on both capital projects and manufacturing execution. Equipment lead times, process development, and ramp-to-volume milestones can become bottlenecks, even for well-funded efforts. That is why analysts often separate “facility readiness” from “commercial readiness” when estimating delivery schedules.

What the report does not provide is detailed, independently verifiable information about specific orders, schedules, or measured progress at Terafab. It also does not cite concrete production targets, yield metrics, or the exact capacity level that would qualify as “commercially significant” mass production. As a result, the 2030 expectation should be treated as an informed forecast rather than a confirmed company plan.

Going forward, market watchers will likely focus on any Tesla disclosures that clarify Terafab milestones. Key items would include updates on equipment installation, commissioning dates, and any references to expected volume ramps. In the absence of new filings or quantified production guidance, the debate will likely remain centered on whether Terafab’s construction pace can translate into fast, high-yield chip output by the company’s preferred timeline.